Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Modular Medical ( (MODD) ) has provided an update.
On December 10, 2025, Modular Medical, Inc. entered into an Underwriting Agreement with Newbridge Securities Corporation for an underwritten public offering of 12,173,000 shares of common stock and accompanying warrants. The offering closed on December 11, 2025, generating approximately $4.68 million in gross proceeds. The company has granted the underwriter a 30-day option to purchase additional shares and warrants to cover over-allotments. This strategic financial move is expected to enhance the company’s market positioning and operational capabilities in the insulin delivery sector.
More about Modular Medical
Modular Medical, Inc. is a medical device company focused on developing next-generation insulin delivery technology. The company aims to make high-quality insulin delivery affordable and easy to use, targeting a broader audience beyond traditional ‘superusers’ to improve diabetes care accessibility.
Average Trading Volume: 1,023,552
Technical Sentiment Signal: Sell
Current Market Cap: $28.72M
See more insights into MODD stock on TipRanks’ Stock Analysis page.